RESUMO
OBJECTIVES: It was aimed to investigate the necessity of antiviral agents in the ISSHL treatment. METHODS: In this study, the patients, diagnosed with sudden hearing loss and admitted in the first 7 days of hearing loss were divided into two groups; a combination therapy was administered to one of the groups, and famciclovir was administered to the other group as an antiviral treatment in addition to the combined therapy. Both groups were compared in terms of levels of recovery. RESULTS: No statistically significant difference was found in the recovery rates between the two groups (p=0.7). CONCLUSION: In this study, the additional antiviral treatment was found to have no effect on the remission rates in patients with ISSHL treated with combined therapy.